No Data
Repurchase collection on December 2nd | Tencent, AIA and other companies have successively repurchased, with Tencent spending HKD 0.701 billion.
According to the document disclosed by hkex on December 3, $tencent (00700.HK)$, $aia (01299.HK)$ and others repurchased shares. ① $tencent (00700.HK)$ repurchased 1.76 million ordinary shares on December 2, involving an amount of 0.701 billion HKD, with a repurchase price ranging from 401.2 HKD to 395.6 HKD per share. Since the repurchase authorization resolution, the total number of securities repurchased has reached 0.199 billion shares, accounting for 2.11% of the total issued shares at the time the ordinary resolution was passed. ② $aia (01299.HK)$ repurchased on December
Eagle Eye Technology - B (02251) spent 0.119 million Hong Kong dollars to repurchase 0.01 million shares on December 2nd.
Eagle Eye Technology - B (02251) announced that it will spend 0.119 million Hong Kong dollars to buy back 1...
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space
Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.
AIRDOC-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATIONTO THE ANNUAL REPORT OF THE COMPANYFOR THE YEAR ENDED DECEMBER 31, 2023
AIRDOC-B: 2024 INTERIM REPORT
No Data
